Leukemia Lymphoma B Cell 2 Cn453923
A type of blood cancer involving B-cells, part of the lymphoma group. It may present with swollen lymph nodes, fatigue, and weight loss. Treatment options include chemotherapy, immunotherapy, and targeted therapies.
Key facts at a glance
- ICD-10
- C80.1
- ICD-11
- 2A00.0
- Body system
- oncologic
- Severity
- severe
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Fatigue
Unexplained weight loss
Persistent fever
Generalized symptoms
(oncologic)Significant symptoms that substantially affect daily functioning.
Frequency: Common at all stages
Bone pain
(oncologic)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Drug therapy and clinical monitoring
Active treatment with regular monitoring by a healthcare provider is recommended.
Immunochemotherapy
Combination of immunotherapy agents with traditional chemotherapy drugs to enhance treatment efficacy against B-cell malignancies. This synergistic approach improves response rates compared to chemotherapy alone.
Monoclonal Antibody Therapy
Targeted antibody therapy specifically designed to recognize and eliminate B-cells expressing particular surface markers. Often combined with chemotherapy or used as maintenance therapy after initial treatment.
Additional treatment options
Autologous Stem Cell Transplant
Harvesting and reinfusion of patient's own stem cells following high-dose chemotherapy to restore bone marrow function. Considered for patients who respond well to initial treatment but are at risk for relapse.
procedureMinimal Residual Disease Testing
Highly sensitive laboratory testing to detect residual cancer cells below levels visible on standard microscopy. Helps guide treatment decisions and identifies patients who may benefit from additional therapy.
monitoringIntegrative Oncology Support
Complementary therapies including acupuncture for symptom management, stress reduction techniques, and gentle exercise programs designed to support overall wellbeing during cancer treatment and recovery.
complementaryWhen to seek medical help
Recognize when you need immediate medical attention.
See a doctor within 24 hours
Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.
Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.
Frequently asked questions
Common questions about this topic.
What is Leukemia Lymphoma B Cell 2 Cn453923?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalMedication Comparisons
Compare medications used to treat Leukemia Lymphoma B Cell 2 Cn453923. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy